Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
Andrew Chow, Fathema Uddin, Michael Liu, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 93-106.e6
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 65
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer
Clare E. Weeden, Velimir Gayevskiy, Claire Marceaux, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 837-852.e6
Open Access | Times Cited: 45
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Supervised discovery of interpretable gene programs from single-cell data
Russell Kunes, Thomas Walle, Max Land, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 7, pp. 1084-1095
Open Access | Times Cited: 40
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
Runxian Wang, Zhenya Liu, Zhiyao Fan, et al.
Cancer Letters (2023) Vol. 567, pp. 216267-216267
Closed Access | Times Cited: 35
Mass‐produced gram‐negative bacterial outer membrane vesicles activate cancer antigen‐specific stem‐like CD8+ T cells which enables an effective combination immunotherapy with anti‐PD‐1
Solchan Won, Changjin Lee, Seoyoon Bae, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 33
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, et al.
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1309-1325
Closed Access | Times Cited: 28
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Yuhan Zhang, Junyi Hu, Kai Ji, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101151-101151
Open Access | Times Cited: 26
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Elucidating stearoyl metabolism and NCOA4-mediated ferroptosis in gastric cancer liver metastasis through multi-omics single-cell integrative mendelian analysis: advancing personalized immunotherapy strategies
Zhongqiu Yang, Yuquan Chen, Yaping Miao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgery
Syrine Abdeljaoued, Alexandre Doussot, Marie Kroemer, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma
Olivia Le Saux, Maude Ardin, Justine Berthet, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Location of CD39+T cell subpopulations within tumors predict differential outcomes in non-small cell lung cancer
Lilian Koppensteiner, Layla Mathieson, Samuel Pattle, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006770-e006770
Open Access | Times Cited: 14
Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer
Chang Liu, Kaiyi Li, Xizhao Sui, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 5
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Roger Li, Nancy Villa, Xiaoqing Yu, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 5
A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma
Xinyu Guo, Tianming Cui, Linmao Sun, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 5
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+T cell infiltration and functional transition
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007230-e007230
Open Access | Times Cited: 11
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity
Jiayi Tan, Colt A. Egelston, Weihua Guo, et al.
EBioMedicine (2024) Vol. 101, pp. 105035-105035
Open Access | Times Cited: 4
Reusability report: Leveraging supervised learning to uncover phenotype-relevant biology from single-cell RNA sequencing data
Yingying Cao, Tiangen Chang, Sahil Sahni, et al.
Nature Machine Intelligence (2024) Vol. 6, Iss. 3, pp. 307-314
Closed Access | Times Cited: 4
How to optimize the immune checkpoint blockade therapy for cancers?
Hui Guo, Yuchuan Hou, Chunxi Wang, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 343-348
Open Access | Times Cited: 4
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer
Yong Zhang, Xiang‐Xiang Chen, Ruo Chen, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types
Zhen Zeng, Tianbei Zhang, Jiajia Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Single Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T Cell Subpopulation that is Correlated with Response to Checkpoint Therapy in Melanoma
Kelly Mahuron, Osmaan Shahid, Prachi Sao, et al.
Cancer Research (2025) Vol. 85, Iss. 8, pp. 1424-1440
Closed Access
Opportunities for Discovery Using Neoadjuvant Immune Checkpoint Blockade in Melanoma
U. J. Nair, Emily Rakestraw, Georgia M. Beasley, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2427-2427
Open Access
Page 1 - Next Page

Scroll to top